The chief financial officer of
Therapeutics has resigned.
Melvyn Davies, who was also company secretary, had been with Silence for 15
years. He will assist the company for up to three months until they find a
Silence, which specialises in treating serious diseases with biotechnology,
also announced the resignation of Iain Ross, chairman and a director of the
board. The board has appointed Jerry Randall, senior independent director, to
Randall said: “I would like to extend my own and the board’s heartfelt thanks
to both Iain and Melvyn for all they have contributed to Silence.”
Does Darwin's theory apply to taxation? Colin ponders...
Colin comments on the effect of Brexit on the influx of partners at KPMG
Colin provides insight into the Tesco and Unilever scandal over Marmite
The Cogital Group recently acquired Baldwins along with Blick Rothenberg, the former BPO division of Visma